Tardif, J.C., et al. (2022) Apolipoprotein C-III Reduction in Subjects with Moderate Hypertriglyceridaemia and at High Cardiovascular Risk. European Heart Journal, 43, 1401-1412.
https://doi.org/10.1093/eurheartj/ehab820

has been cited by the following article:

• TITLE: Etitiological Relationship between Hyperlipidemia and Acute Pancreatitis

  AUTHORS: Hanhui Li, Jie Li, Xiaoping Tan, Qing Zhang

  KEYWORDS: Hyperlipidemia, Acute Pancreatitis, High-Fat Diet, Cause

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.12 No.5, May 11, 2024

  ABSTRACT: Hyperlipidemia is a kind of pancreatitis caused by high triglyceride levels in the blood. The morbidity and mortality of this disease continue to increase worldwide, and it has become one of the most common gastrointestinal diseases in developed countries worldwide. Although many studies have been conducted, the pathogenesis still cannot be defined. Many studies have shown that this may be related to the triglyceride decomposition products free fatty acids are the main toxic substances, which can directly damage pancreatic acinar cells and vascular endothelial cells, causing tissue ischemia and acidic environment. Therefore, this paper focuses on the correlation of triglycerides and their decomposition products in plasma and provides evidence on the pathogenesis of AP and the disease progression of AP. Finally, the future potential to prevent and treat acute pancreatitis by some new drugs to reduce plasma triglycerides is summarized.